PureTech Health plc (NASDAQ:PRTC – Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $23.00, but opened at $21.80. PureTech Health shares last traded at $21.70, with a volume of 1,690 shares traded.
PureTech Health Stock Performance
The firm’s 50-day moving average is $22.71 and its two-hundred day moving average is $25.86.
Institutional Trading of PureTech Health
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 6,900 shares of the company’s stock, valued at approximately $197,000. Institutional investors own 0.04% of the company’s stock.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Read More
- Five stocks we like better than PureTech Health
- Compound Interest and Why It Matters When Investing
- 3 Small Cap Stocks That Insiders Are Buying
- Market Cap Calculator: How to Calculate Market Cap
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- 3 Warren Buffett Stocks to Buy Now
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
